Latest News about SMMT
Recent news which mentions SMMT
Consumer Sentiment Drops 10%, UnitedHealth Under Investigation: What's Driving Markets Friday?
February 21, 2025
From Benzinga
3 Stocks That Could Trounce the Market in 2025
February 17, 2025
From Motley Fool
2 Stocks That Could Soar Again in 2025
February 08, 2025
From Motley Fool
Jim Cramer Says AppFolio Is A 'Good One,' But Summit Therapeutics? 'Can't Go There'
February 03, 2025
From Benzinga
Tickers
SMMT
From Motley Fool
Netflix, Palantir And Moderna Are Among Top 12 Large Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio?
January 26, 2025
From Benzinga
From Motley Fool
Why Summit Therapeutics Stock Is Jumping Today
January 21, 2025
From Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
January 20, 2025
From Benzinga
From Benzinga
This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
January 08, 2025
From Benzinga
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
January 07, 2025
From Benzinga
Prediction: These 3 Healthcare Stocks Will Soar in 2025
January 04, 2025
From Motley Fool
3 Stocks That Could Be Monster Winners in 2025
December 29, 2024
From Motley Fool
3 Stocks That Could Turn $1,000 into $5,000 by 2030
December 20, 2024
From Motley Fool
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
December 18, 2024
From Motley Fool
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street
December 15, 2024
From Motley Fool
Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today
December 14, 2024
From Motley Fool
Why Summit Therapeutics Stock Rocketed 6% Higher on Friday
December 06, 2024
From Motley Fool
Billionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% Higher
December 02, 2024
From Motley Fool
3 Monster Stocks in the Making
November 23, 2024
From Motley Fool
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
November 09, 2024
From Benzinga
2 Hot Biopharma Stocks to Buy and Hold for 5 Years
November 08, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|